Renaissance Technologies LLC boosted its stake in shares of Kindred Healthcare, Inc. (NYSE:KND) by 18.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 307,052 shares of the health services provider’s stock after buying an additional 47,772 shares during the period. Renaissance Technologies LLC owned approximately 0.36% of Kindred Healthcare worth $2,564,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. TFS Capital LLC purchased a new stake in Kindred Healthcare during the first quarter valued at $104,000. First Citizens Bank & Trust Co. raised its stake in Kindred Healthcare by 8.9% in the first quarter. First Citizens Bank & Trust Co. now owns 15,462 shares of the health services provider’s stock valued at $129,000 after buying an additional 1,260 shares during the period. Wedbush Securities Inc. raised its stake in Kindred Healthcare by 4.3% in the first quarter. Wedbush Securities Inc. now owns 19,300 shares of the health services provider’s stock valued at $161,000 after buying an additional 800 shares during the period. Mason Street Advisors LLC raised its stake in Kindred Healthcare by 7.0% in the first quarter. Mason Street Advisors LLC now owns 19,906 shares of the health services provider’s stock valued at $166,000 after buying an additional 1,297 shares during the period. Finally, SG Americas Securities LLC raised its stake in Kindred Healthcare by 28.1% in the first quarter. SG Americas Securities LLC now owns 20,915 shares of the health services provider’s stock valued at $175,000 after buying an additional 4,584 shares during the period. 89.79% of the stock is currently owned by institutional investors.

Kindred Healthcare, Inc. (NYSE KND) traded down 3.33% during mid-day trading on Tuesday, hitting $7.25. The company had a trading volume of 130,756 shares. The company’s 50 day moving average price is $10.14 and its 200-day moving average price is $9.23. The company’s market cap is $630.89 million. Kindred Healthcare, Inc. has a one year low of $5.65 and a one year high of $11.90.

Kindred Healthcare (NYSE:KND) last announced its earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.59 billion. Kindred Healthcare had a positive return on equity of 3.49% and a negative net margin of 16.31%. Kindred Healthcare’s revenue for the quarter was down 4.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.38 earnings per share. Equities research analysts anticipate that Kindred Healthcare, Inc. will post $0.57 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/15/renaissance-technologies-llc-raises-position-in-kindred-healthcare-inc-knd.html.

KND has been the topic of several research reports. Deutsche Bank AG lowered their target price on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, August 7th. Barclays PLC reissued a “buy” rating and issued a $13.00 target price (up previously from $11.00) on shares of Kindred Healthcare in a report on Sunday, May 7th. Zacks Investment Research raised Kindred Healthcare from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a report on Wednesday, May 3rd. Royal Bank Of Canada reissued a “hold” rating and issued a $10.00 target price on shares of Kindred Healthcare in a report on Monday, May 15th. Finally, BidaskClub lowered Kindred Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, July 12th. Four investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $9.94.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Institutional Ownership by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Stock Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related stocks with our FREE daily email newsletter.